Breaking News Instant updates and real-time market news.

P

Pandora

$10.75

-0.27 (-2.45%)

, AMZN

Amazon.com

$896.23

-6.13 (-0.68%)

14:37
04/13/17
04/13
14:37
04/13/17
14:37

Private equity firms should avoid investing in Pandora, says BTIG

BTIG analyst Rich Greenfield noted that the New York Post said Pandora has held talks with private equity firms about a potential capital raise, but he believes the firms should avoid investing as he thinks its core business is struggling and its new Premium service "faces an uphill battle" given competition from Spotify as well as offerings from Apple (AAPL) and Amazon (AMZN). Greenfiled, who is increasingly less confident that Pandora will sell itself, has a Neutral rating on the shares.

P

Pandora

$10.75

-0.27 (-2.45%)

AMZN

Amazon.com

$896.23

-6.13 (-0.68%)

AAPL

Apple

$141.80

0.17 (0.12%)

  • 16

    May

  • 23

    May

P Pandora
$10.75

-0.27 (-2.45%)

02/10/17
ADAM
02/10/17
NO CHANGE
Target $18
ADAM
Buy
Pandora likely to create more value as independent company, says Canaccord
Canaccord analyst Michael Graham said Pandora's Q4 results were solid and inline with its preannouncement. He said his thesis remains intact as he continues to see strength in subscriber conversion, which argues well for the company to remain independent in the near-term, which he believes will create the most value for shareholders. Graham reiterated his Buy rating and $18 price target on Pandora shares.
02/28/17
ADAM
02/28/17
NO CHANGE
Target $18
ADAM
Buy
Pandora Premium launch on track, says Canaccord
Canaccord analyst Michael Graham said Pandora's Premium launch appears to be on track for late March and he expects the initial conversion trends should be solid. The analyst said the ad load sampling shows continued high ad load and a resurgence in local advertising. He notes the most important metric over the next 6-12 months will be subscriber growth and he believes the company can deliver. Graham reiterated his Buy rating and $18 price target on Pandora shares.
03/22/17
PIPR
03/22/17
NO CHANGE
Target $18
PIPR
Overweight
Piper says survey supports positive view of Pandora shares
Piper Jaffray analyst Stan Meyers continues to believe that Liberty Media (LMCA) and SiriusXM (SIRI) remain a potential buyer of Pandora Media (P) with the price likely dependent on the success of Pandora's new Premium and Plus offerings. The analyst conducted a second survey of Pandora users and found that demand from current listeners for the Pandora Premium remained largely unchanged at 15% while interest in Pandora Plus declined from 28% to 14%. The survey shows "meaningful pent-up demand" for Pandora's new offerings, Meyers tells investors in a research note. He believes this supports his positive view on the shares. Meyers has an Overweight rating on Pandora with an $18 price target.
04/11/17
MACQ
04/11/17
NO CHANGE
Target $5.85
MACQ
Outperform
Sirius XM focus should be on CRB, not Pandora, says Macquarie
Macquarie analyst Amy Young said Pandora (P) interest and digital threats remain in he background, but the greater unknown for Sirius (SIRI) is the upcoming CRB hearing this month to determine the royalty rate through 2022. The analyst expects a 100bps bump in 2018, similar to 2012, with a 50bps escalator through 2022, and other costs to remain under control, which should offset R&D/marketing investments for 360L. Young remains bullish on Sirius' the resiliency of Sirius core model and continues to expect net adds, free cash flow, and buybacks to exceed expectations. The analyst has an Outperform rating and $5.85 price target on Sirius XM shares.
AMZN Amazon.com
$896.23

-6.13 (-0.68%)

04/13/17
LEHM
04/13/17
NO CHANGE
Target $1120
LEHM
Overweight
Barclays still loves Amazon, but 'trending cautiously' into earnings
In a research note titled "Love the Long-Term Story, But Treading Cautiously into 1Q," Barclays analyst Ross Sandler says he expects Amazon.com's upcoming earnings report to be a "mixed bag". The analyst sees the company reporting in-line results and guiding consolidated segment operating income below Q2 estimates, which he views as "aggressive." Ross recommends any post-earnings selloff as a buying opportunity. Amazon's investments today should bring benefits in 2018 and beyond, he argues. The analyst keeps an Overweight rating on the shares with a $1,120 price target.
04/12/17
JPMS
04/12/17
NO CHANGE
JPMS
Overweight
TiVo deal with Roku validates strength of OTT patent portfolio, says JPMorgan
After TiVo (TIVO) announced a multi-year licensing agreement with Roku, JPMorgan analyst Sterling Auty says the deal further validates the strength of OTT patent portfolio. The analyst notes that recent multi-year OTT contracts with Netflix (NFLX), Time Warner's (TWX) HBO and now Roku demonstrates the combined strength of Rovi and TiVo patent portfolio, which has much broader applicability. He believes TiVo will be able to leverage its recent traction to work on signing the remaining OTT providers like Amazon (AMZN). Auty reiterates an Overweight rating on TiVo's shares.
04/12/17
JPMS
04/12/17
NO CHANGE
JPMS
JPMorgan thinks JANA wants strategic partner for Whole Foods
JPMorgan analyst Ken Goldman says he increasingly believes that JANA Partners' primary mission with Whole Foods Market (WFM) may less be about operational improvements than creating value for shareholders via a strategic partner. The analyst questions how JANA is confident that management and the board are unwilling to talk to potential suitors being that the activist is yet to engage the company. JANA, with many relationships in the supermarket industry, could be communicating with third parties, Goldman tells investors in a research note after Bloomberg reported that Amazon.com (AMZN) mulled a purchase of Whole Foods prior to JANA's presence. The analyst says "don't sleep" on a possible merger between Whole Foods and a private company since many of the U.S.'s larger supermarket chains are privately held. Public companies could have interest in Whole Foods, but a deal with Kroger (KR) is unlikely, Goldman contends.
04/10/17
04/10/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Tesla (TSLA) upgraded to Overweight from Neutral at Piper Jaffray analyst Alexander Potter saying while Model 3 production headlines could create stock volatility, growth investors "can't afford to ignore this stock." Tesla's products have a "captivating impact on consumers and shareholders alike," an advantage that will be hard to replicate, the analyst adds. Potter is more convinced following meetings with management that Model 3 deliveries will begin in 2017. The analyst raised his price target for the shares to $368 from $223. 2. Amazon.com (AMZN) upgraded to Buy from Hold at Needham with analyst Kerry Rice saying he believes its established dominance in U.S. is sustainable with Prime, mobile penetration and third-party growth. Internationally, the analyst believes Europe provides the most near-term upside, while he views India as one of "the most exciting" long-term opportunities. Rice also believes AWS should continue to be a key driver for the company's bottom line growth. 3. Wells Fargo (WFC) upgraded to Neutral from Underweight at Piper Jaffray with analyst Kevin Barker saying headwinds from the account scandal are now embedded in consensus estimates and the stock's valuation. The analyst raised his price target for the shares to $55 from $52. 4. Ulta Beauty (ULTA) upgraded to Buy from Hold at Loop Capital with analyst Anthony Chukumba saying Ulta is the most compelling fundamental story in retail today. Chukumba feels the struggles of high-end department stores plays right into the company's hands. He also thinks Ulta is overdue for a stock split. 5. Skechers (SKX) upgraded to Neutral from Negative at Susquehanna with analyst Sam Poser saying shares are fairly valued and reflect near-term challenges following recent share weakness. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
AAPL Apple
$141.80

0.17 (0.12%)

04/13/17
RBCM
04/13/17
NO CHANGE
RBCM
Acquiring Disney would be 'logical' for Apple, says RBC Capital
RBC Capital analyst Amit Daryanani says that it would be "logical" for Apple (AAPL) to acquire Disney (DIS) if cash repatriation legislation is passed. The acquisition would make sense in light of Apple's "focus on services" "and its inability to replicate its music/iTunes strategy into content/media," the analyst stated. He sees the chances of such a deal as "greater than 0%," but admits that the odds of it happening are "low." Daryanani remains upbeat on Apple's fundamentals and keeps an Outperform rating on the shares.
04/13/17
MACQ
04/13/17
NO CHANGE
Target $156
MACQ
Outperform
Apple now largest Western software seller in China, says Macquarie
Macquarie analyst Ben Schachter said recent data from App Annie and his own estimates, indicates Apple (AAPL), through app store sales, is now the largest Western software seller in China. Schachter estimates gross revenue of $5B-$6B, and said if Apple maintains its China share, by 2020 gross China iOS App Store purchases could be at least $16B. The analyst rates Apple an Outperform and a $156 price target.
04/13/17
SPHN
04/13/17
NO CHANGE
Target $95
SPHN
Overweight
Potential competitive threat to Dexom 'more distant in nature,' says Stephens
Following a report by CNBC alleging Apple (AAPL) is in late stages of developing an optical continuous blood glucose sensor, Stephens analyst Chris Cooley reiterates an Overweight rating and $95 price target on Dexom's (DXCM) shares. While the news will likely cause concern, the analyst says investors must recall any potential entrant will have to match Dexom's industry leading clinical efficacy. Given that he is not aware of any formal clinical trials underway by Apple, a pre-requisite for domestic commercialization, Cooley believes this potential threat appears more distant in nature.
04/13/17
COWN
04/13/17
NO CHANGE
Target $90
COWN
Outperform
Cowen sees Apple threat to Dexcom as 'only hype/hope' at this point
The slide in Dexcom (DXCM) shares this morning is "seemingly due" to a report saying Apple (AAPL) is working on a non-invasive glucose sensor, said Cowen analyst Doug Schenkel, but he cautions that other companies have been trying to do the same for decades and all have failed. While you can " never say never," Schenkel views it as "extremely unlikely" that Apple has succeeded and he will not be worried about this threat to Dexcom until he sees data, he tells investors. Beyond today's dip, a move in Dexcom shares from their recent highs is due to heightened investor focus on nearer-term competitive products coming later this year from Medtronic (MDT) and Abbott (ABT), noted Schenkel, who keeps an Outperform rating and $90 price target on Dexcom.

TODAY'S FREE FLY STORIES

TSLA

Tesla

$315.05

2.55 (0.82%)

10:21
11/18/17
11/18
10:21
11/18/17
10:21
Periodicals
Tesla new super car to cost $200,000, Recode says »

Alongside its new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 16

    Jan

GT

Goodyear Tire

$29.94

0.63 (2.15%)

10:17
11/18/17
11/18
10:17
11/18/17
10:17
Hot Stocks
Goodyear Tire, NASCAR extend relationship »

NASCAR and Goodyear Tire…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 09

    Jan

  • 16

    Jan

HMC

Honda

$32.62

0.02 (0.06%)

10:05
11/18/17
11/18
10:05
11/18/17
10:05
Periodicals
Honda recalls 900,000 minivans on tip forward seats, Reuters says »

Honda Motor is recalling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$88.43

-0.82 (-0.92%)

09:48
11/18/17
11/18
09:48
11/18/17
09:48
Periodicals
Activist investors Nelson Peltz still in P&G picture, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHGE

Baker Hughes

$30.91

0.76 (2.52%)

, GE

General Electric

$18.21

-0.04 (-0.22%)

09:39
11/18/17
11/18
09:39
11/18/17
09:39
Periodicals
Buy Baker Hughes, Barron's says »

While it is "not…

BHGE

Baker Hughes

$30.91

0.76 (2.52%)

GE

General Electric

$18.21

-0.04 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

CSCO

Cisco

$35.90

0.02 (0.06%)

09:19
11/18/17
11/18
09:19
11/18/17
09:19
Periodicals
More needed for Cisco to have 'groove back,' Barron's says »

While the Nasdaq…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 29

    Nov

  • 11

    Dec

  • 17

    Jan

  • 17

    Jan

IBM

IBM

$148.97

-0.15 (-0.10%)

09:10
11/18/17
11/18
09:10
11/18/17
09:10
Periodicals
IBM could be next to fetch higher valuation, Barron's says »

Investors are warming to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

GE

General Electric

$18.21

-0.04 (-0.22%)

09:05
11/18/17
11/18
09:05
11/18/17
09:05
Periodicals
Option play offer some help given GE dividend, depressed stock, Barron's says »

While wagering against…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$18.21

-0.04 (-0.22%)

09:00
11/18/17
11/18
09:00
11/18/17
09:00
Periodicals
Risk remains after GE dividend cut, Barron's says »

While buying General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Time Warner

$88.72

0.71 (0.81%)

, T

AT&T

$34.51

-0.01 (-0.03%)

08:21
11/18/17
11/18
08:21
11/18/17
08:21
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

TWX

Time Warner

$88.72

0.71 (0.81%)

T

AT&T

$34.51

-0.01 (-0.03%)

NYT

New York Times

$17.65

0.05 (0.28%)

TEX

Terex

$44.82

0.8 (1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

TPIC

TPI Composites

$19.06

-0.97 (-4.84%)

07:25
11/18/17
11/18
07:25
11/18/17
07:25
Conference/Events
TPI Composites to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

SYNA

Synaptics

$38.21

0.57 (1.51%)

04:55
11/18/17
11/18
04:55
11/18/17
04:55
Conference/Events
Synaptics management to meet with KeyBanc »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

, BRCD

Brocade

18:01
11/17/17
11/17
18:01
11/17/17
18:01
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

BRCD

Brocade

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

AVGO

Broadcom

$271.86

-0.25 (-0.09%)

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

LMOS

Lumos Networks

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 06

    Dec

WGL

WGL Holdings

$84.32

-0.14 (-0.17%)

18:01
11/17/17
11/17
18:01
11/17/17
18:01
Earnings
WGL Holdings reports Q4 adjusted EPS (17c), consensus (19c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

, LMOS

Lumos Networks

17:58
11/17/17
11/17
17:58
11/17/17
17:58
Hot Stocks
Tactile Systems to replace Lumos Networks in S&P 600 at open on 11/22 »

EQT Infrastructure…

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

LMOS

Lumos Networks

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

, MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

17:56
11/17/17
11/17
17:56
11/17/17
17:56
Hot Stocks
Breaking Hot Stocks news story on Invesco Mortgage, MKS Instruments »

Invesco Mortgage to…

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

, BRCD

Brocade

17:55
11/17/17
11/17
17:55
11/17/17
17:55
Hot Stocks
MKS Instruments to replace Brocade in S&P 400 at open on 11/22 »

S&P 500 constituent…

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

BRCD

Brocade

AVGO

Broadcom

$271.86

-0.25 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

UQM

UQM Technologies

$1.18

0.015 (1.29%)

17:24
11/17/17
11/17
17:24
11/17/17
17:24
Syndicate
Breaking Syndicate news story on UQM Technologies »

UQM Technologies files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$238.02

-1.35 (-0.56%)

17:23
11/17/17
11/17
17:23
11/17/17
17:23
Periodicals
Goldman Sachs has $510M lawsuit dismissed, Reuters reports »

A $510M lawsuit that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VICL

Vical

$1.94

-0.02 (-1.02%)

17:18
11/17/17
11/17
17:18
11/17/17
17:18
Hot Stocks
Breaking Hot Stocks news story on Vical »

Biotechnology Value Fund…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$140.31

-1.4 (-0.99%)

17:18
11/17/17
11/17
17:18
11/17/17
17:18
Hot Stocks
Ligand director sells 5,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$140.31

-1.4 (-0.99%)

17:17
11/17/17
11/17
17:17
11/17/17
17:17
Hot Stocks
Ligand CFO sells 6,559 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$140.31

-1.4 (-0.99%)

17:17
11/17/17
11/17
17:17
11/17/17
17:17
Hot Stocks
Ligand CEO sells 5,269 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBI

MBIA

$9.01

0.13 (1.46%)

17:15
11/17/17
11/17
17:15
11/17/17
17:15
Hot Stocks
Breaking Hot Stocks news story on MBIA »

Fine Capital Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RBCN

Rubicon

$8.07

0.1218 (1.53%)

17:03
11/17/17
11/17
17:03
11/17/17
17:03
Hot Stocks
Breaking Hot Stocks news story on Rubicon »

Bandera Partners reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.